Figure 2From: Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis Adjusted odds ratios for chemotherapy -induced neutropenic complications requiring inpatient care, by duration of filgrastim prophylaxis*. *Results adjusted for patient, cancer, and chemotherapy characteristics.Back to article page